Plain-English translation of NCT06006637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a wearable headband device called Cognilum that uses near-infrared light to stimulate specific areas of the brain in autistic children. The device is designed to be safe and comfortable to wear, and researchers want to see if it can reduce autism symptoms and improve social skills. Half of the children will wear the device with the light turned on, and half will wear it without the light activated, so researchers can compare the results fairly.
Many autistic children struggle with social communication and other autism-related symptoms, and current treatments have limited options. This trial exists to test whether this new non-invasive light therapy approach could offer a safe, additional way to help reduce these symptoms.
You likely qualify if…
You likely don't qualify if…
If your child is chosen for this study, they will wear the Cognilum headband during treatment sessions. The child will be randomly assigned to either receive the active light treatment or a sham version where the device looks the same but the light is not turned on—neither you nor the researchers will know which group your child is in until the study is over. The researchers will measure changes in autism symptoms using standardized rating scales before and after treatment to see if the light therapy made a difference.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
United States